Navigation Links
Discovery of the first resistance gene to rice yellow mottle virus

resistant rice was modified by transgenically introducing the allele for susceptibility of this gene. The descendents of transformed plants that manifested restored susceptibility always showed the presence of the transgene .

Viruses are built with a small genome coding for a limited number of proteins (5 in the RYMVs). They therefore need their host's proteins in order to accomplish each stage of their infection cycle. One of the proteins that the RYMV requires appears to be the eIF(iso)4G translation initiation factor coded by the Rymv1 gene which is probably involved in viral protein translation, but also perhaps in other processes such as the virus's movement within the cell.

The research team discovered mutations of the gene they analysed in three different resistant varieties. These are distinct but are situated in the same domain of the gene in a patch on the surface favourable for interaction with the virus. In these varieties, the mutation does not appear to alter the protein's role in its primary biological functions, but can prevent its interaction with the virus which is then blocked in one of the stages of its infectious cycle.

In parallel, a team of IRD virologists showed that it was possible to carry out laboratory selection of RYMV strains that break the gene's resistance and that the process involved was determined by mutations in one of the viral proteins. The two approaches are now being combined in order to determine the molecular mechanisms of resistance or susceptibility on the basis of direct interactions between the rice protein and that of the virus. Understanding of these mechanisms will give clues as to the best ways of making long-term use of this resistance gene.

Another strategy developed by the IRD for combating this virus involves introducing part of the viral genes into the plant genome by transgenesis, as has been done in other plant/virus interactions, with the aim of inducing resistance to RY
'"/>

Source:Institut de Recherche Pour le D茅veloppement


Page: 1 2 3

Related biology news :

1. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
2. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
3. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
4. Discovery Could Lead To Novel Approaches In HIV Treatment
5. Discovery Promises Simpler Therapy for Sickle Cell Disease
6. Discovery may lead to better Candidiasis drug
7. Protein Discovery Could Unlock The Secret To Better TB Treatment
8. Discovery clarifies role of peptide in biological clock
9. Eliminate Data Analysis Bottlenecks in Drug Discovery
10. Discovery of New Dopamine Action May Yield Alternative Psychiatric Drugs
11. Discovery could be key to bioterrorism defense

Post Your Comments:
(Date:11/5/2009)...at Yale University have developed synthetic molecu...e to HIV and HIV-infected cells, as well as to pro...ne in the Journal of the American Chemical Societ... these diseases. , The molecules called "antib... "antibody-recruiting molecule targeting prostate ...
(Date:11/4/2009)...he cities of Long Beach and Riverside are responsi...ildhood asthma, and the true impact of air polluti...en underestimated, according to researchers at the... study, which appears in an online edition of the ...t nine percent of all childhood asthma cases in Lo...
(Date:11/4/2009)...t Norman has received more than $10 million in res... the federal stimulus program, bringing thetotal a...rs to $23 million. Thirty-three projects achieved...logy to weather. , "The university has thoughtfu...reasof scholarly excellence to federal agency prio...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2USC study finds big air pollution impacts on local communities 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry 49590 1Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry 49590 2Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry 49590 3Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer 49588 1Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer 49588 2Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer 49588 3Cordex Signs European Development Partnership for ATPotent 28TM 29 Sperm Motility Drug 4623 1Cordex Signs European Development Partnership for ATPotent 28TM 29 Sperm Motility Drug 4623 2Cordex Signs European Development Partnership for ATPotent 28TM 29 Sperm Motility Drug 4623 3Cordex Signs European Development Partnership for ATPotent 28TM 29 Sperm Motility Drug 4623 4Cordex Signs European Development Partnership for ATPotent 28TM 29 Sperm Motility Drug 4623 5
...LLE, Fla. --- The observation that males evolve mo... century biologist Charles Darwin noted the majest...e plainness of the peahens. , No matter the speci... more melodious warbles in an eternal competition ...election. , Why males are in evolutionary overdri...
...ds rivers, lakes, reservoirs and groundwater as we...s of freshwater to support terrestrial life and hu...ucial to manage these water resources for the bene...vide crucial forecasting services to prevent water...ese tasks are routinely undertaken by the National...
...st State of the Carbon Cycle Report for North Amer... Change Science Program, finds the continents carb... emissions. North American sources release nearly... year, mostly as carbon dioxide. Carbon sinks su...mount, but these current sinks may turn into new s...
Other Biology News:Simple reason helps males evolve more quickly 2Simple reason helps males evolve more quickly 3Space technology put into service for global water resources observations 2First-ever 'State of the Carbon Cycle Report' finds troubling imbalance 2
(Date:11/6/2009)...NA, Austria, November 6 EUCODIS Bi...acturing, and marketing enzymes for the,chemical i... research,agreement with Bio Sidus, the leading bi... The agreement gives EUCODIS Bioscience exclusiv... to Bio Sidus, proprietary collection of,psychroph...
(Date:11/6/2009)...ALLEY, Calif., Nov. 6 Calbiotech, ...all Business Innovative Research (SBIR) Phase I co...ial command. Under terms of the agreement, Calbiot...for the diagnosis of Dengue virus. ,, Dengue...ts a major threat to military forces deployed to t...
(Date:11/6/2009)... Calif., Nov. 6 Intarcia Therapeut... ITCA 650 (DUROS® continuous delivery of exen...s at the Ninth Annual Diabetes Technology Meeting ...scom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,,...ia ITCA 650 Lowers Plasma Glucose, HbA1c and Reduc...
(Date:11/5/2009)...ATION -- Gone hybrid . . . , Fuel economy rati...w posted at the www.fueleconomy.gov web site, wh...intains for the U.S. Department of Energy and the ...top 10 vehicles on the best fuel economy list are ...city; 48 highway). "This list proves that hybrids ...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
... 31 For the first time, scientists have shown tha...g an embryo) may be a potential new source of stem... prepublished online on February 12, 2009, in Blo...of Hematology. , , "Building on observations mad...whether stem cells could be detected in amniotic f...
...h 31 ArunA Biomedical, Inc., a leader in human em...y that it has co-developed a validated kit to prod...stems now part of Thermo Fisher. , , (Logo: ...U003LOGO ) , , In the spirit of collaboration A...e complete and fully validated induced pluripotent...
...ch 31 Intrinsic Bioprobes, Inc. today announced t...stitute to develop effective technologies for accu...ptides that improve diagnostic capabilities by eff...tes. The total cost of the two-and-a-half-year con...deral money provided by the NCI, and $146,088 is t...
Other Biology Technology:Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies 2Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies 3ArunA Biomedical Announces Co-development of Fully Validated Induced Pluripotent Stem Cell Kit 2Intrinsic Bioprobes, Inc. Enters into a $1.27M Contract with the National Cancer Institute to Develop Multiplex Mass Spectrometric Immunoassays for Detection of Low Abundance Cancer-Related Proteins 2
Mouse Anti-Human ULBP-3 Monoclonal Antibody, Unconjugated, Clone 166514 from R&D Systems
Rabbit Anti-Human CDC23 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-CRIPT Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-RFP Epitope Tag Antibody, Unconjugated from ABR-Affinity BioReagents
Biology Products: